MedPath
HSA Approval

HOVID-GRISEOFULVIN 500 TABLET B.P. 500mg

SIN07993P

HOVID-GRISEOFULVIN 500 TABLET B.P. 500mg

HOVID-GRISEOFULVIN 500 TABLET B.P. 500mg

February 2, 1995

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

D01BA01

griseofulvin

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

HOVID Bhd.

Active Ingredients

GRISEOFULVIN

500.00 mg

Griseofulvin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HOVID-GRISEOFULVIN 500 TABLET B.P. 500mg - HSA Approval | MedPath